Search Results
Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China
Search for other papers by Jinrong Fu in
Google Scholar
PubMed
Search for other papers by Zihao Fan in
Google Scholar
PubMed
Search for other papers by Liang He in
Google Scholar
PubMed
Search for other papers by Qian Liu in
Google Scholar
PubMed
Search for other papers by He Liu in
Google Scholar
PubMed
Search for other papers by Yushu Li in
Google Scholar
PubMed
Search for other papers by Haixia Guan in
Google Scholar
PubMed
Introduction Autoimmune thyroiditis (AIT), also referred to as Hashimoto’s thyroiditis (HT) or chronic lymphocytic thyroiditis, is a common autoimmune disorder with a prevalence of 0.3–1.5 cases per 1000 subjects per year ( 1 ). AIT is
INSERM 1086 ANTICIPE, Caen University, Caen, France
Search for other papers by Renaud Ciappuccini in
Google Scholar
PubMed
Search for other papers by Virginie Saguet-Rysanek in
Google Scholar
PubMed
Search for other papers by Marine Dorbeau in
Google Scholar
PubMed
Search for other papers by Justine Lequesne in
Google Scholar
PubMed
Search for other papers by Camille Linard in
Google Scholar
PubMed
Search for other papers by Sophie Lefevre-Arbogast in
Google Scholar
PubMed
Search for other papers by Bénédicte Clarisse in
Google Scholar
PubMed
Search for other papers by Stéphane Bardet in
Google Scholar
PubMed
prostate cancer and were related to chronic autoimmune thyroiditis (CAT) ( 4 , 5 ). Diffuse thyroid uptake is also a well-known pattern in patients with CAT on 18 F-Fluorodeoxyglucose ( 18 FDG) PET/CT ( 6 , 7 ). Although some authors showed that thyroid
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Search for other papers by Liliana Ribeiro Santos in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Search for other papers by Inês Vasconcelos Bessa in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Public Health Unit, ACES Baixo Mondego, Coimbra, Portugal
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Department of Endocrinology, Hospital University Centre of São João, Porto, Portugal
Search for other papers by Celestino Neves in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease (AITD) is one of the most prevalent groups of autoimmune diseases ( 1 ). Hashimoto’s thyroiditis (HT) and Graves' disease (GD) are the most significant AITDs ( 2 ), GD being around ten times less common
Search for other papers by Joanna Bogusławska in
Google Scholar
PubMed
Search for other papers by Marlena Godlewska in
Google Scholar
PubMed
Search for other papers by Ewa Gajda in
Google Scholar
PubMed
Search for other papers by Agnieszka Piekiełko-Witkowska in
Google Scholar
PubMed
manifestations of AITD are Graves’ disease (GD) and Hashimoto’s thyroiditis (HT). The additional, less prevalent AITDs include postpartum thyroiditis, drug-induced thyroiditis, thyroiditis associated with polyglandular autoimmune syndromes ( 2 ). Both HT and GD
Search for other papers by Leonidas Duntas in
Google Scholar
PubMed
hormone concentrations, and titers of autoantibodies in patients with chronic autoimmune thyroiditis (CAIT). The authors are to be congratulated on the excellent planning and conduction of this randomized controlled trial (RCT), which has provided several
Search for other papers by Liyuan Liu in
Google Scholar
PubMed
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Lei Chen in
Google Scholar
PubMed
Search for other papers by Yang Zhang in
Google Scholar
PubMed
Search for other papers by Guizhi Lu in
Google Scholar
PubMed
Search for other papers by Ying Gao in
Google Scholar
PubMed
Search for other papers by Junqing Zhang in
Google Scholar
PubMed
Introduction Hashimoto’s thyroiditis (HT) is a common autoimmune thyroid disease characterized by goitre, lymphoplasmacytic infiltration of parenchyma, and positivity for serum antibodies specific to thyroid antigens (including thyroid
Search for other papers by Chenxu Zhao in
Google Scholar
PubMed
Search for other papers by Zhiming Sun in
Google Scholar
PubMed
Search for other papers by Shuaihang Wang in
Google Scholar
PubMed
Search for other papers by Jixin Zhang in
Google Scholar
PubMed
Search for other papers by Jumei Liu in
Google Scholar
PubMed
Search for other papers by Lei Chen in
Google Scholar
PubMed
Search for other papers by Guizhi Lu in
Google Scholar
PubMed
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Ying Gao in
Google Scholar
PubMed
Introduction Hashimoto’s thyroiditis (HT) is an organ-specific autoimmune disease characterized by increased levels of thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb), which primarily belong to the IgG class ( 1
Search for other papers by Michele Marinò in
Google Scholar
PubMed
Search for other papers by Giovanna Rotondo Dottore in
Google Scholar
PubMed
Search for other papers by Francesca Menconi in
Google Scholar
PubMed
Search for other papers by Simone Comi in
Google Scholar
PubMed
Search for other papers by Giada Cosentino in
Google Scholar
PubMed
Search for other papers by Roberto Rocchi in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Search for other papers by Michele Figus in
Google Scholar
PubMed
Search for other papers by Ferruccio Santini in
Google Scholar
PubMed
’ hyperthyroidism ( 1 , 2 ). GO can also be observed in a minority of patients with hypothyroid autoimmune thyroiditis or in the absence of overt thyroid dysfunction ( 2 ). Overall, GO is quite rare (0.54–0.9 cases/100,000/year in men, 2.67–3.3 cases/100,000/year
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
National Board of Health, Nuuk, Greenland
Search for other papers by Paneeraq Noahsen in
Google Scholar
PubMed
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
Department of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland
Search for other papers by Karsten F Rex in
Google Scholar
PubMed
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Queen Ingrid’s Health Care Centre, Nuuk, Greenland
Search for other papers by Gert Mulvad in
Google Scholar
PubMed
Search for other papers by Hans Christian Florian-Sørensen in
Google Scholar
PubMed
Search for other papers by Michael Lynge Pedersen in
Google Scholar
PubMed
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
Department of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland
Department of Geriatric Medicine, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
J Shan L Bai X Li Y Li N Li Z More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels . European
Department of Women’s and Children’s Health, Pediatric Endocrinology Unit, Padua University Hospital, Padua, Italy
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Cristina Clausi in
Google Scholar
PubMed
Search for other papers by Ilaria Piva in
Google Scholar
PubMed
Search for other papers by Yi Hang Zhu in
Google Scholar
PubMed
Search for other papers by Alberto Mondin in
Google Scholar
PubMed
Search for other papers by Maria Chiara Pedron in
Google Scholar
PubMed
Search for other papers by Susi Barollo in
Google Scholar
PubMed
Search for other papers by Loris Bertazza in
Google Scholar
PubMed
Search for other papers by Giulia Midena in
Google Scholar
PubMed
Search for other papers by Raffaele Parrozzani in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
orbital fat and extraocular muscles ( 1 ). These changes cause enlarged extraocular muscles and orbital protrusion. TED is the major extrathyroidal manifestation of Graves’ disease (GD), but it may also be present in Hashimoto’s thyroiditis (HT) or rarely